Skip to content
healthcare.dev

DANZITEN

NDC 24338-154, nilotinib, tablet, from Azurity Pharmaceuticals, Inc..

Product NDC
24338-154
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219293
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24338-154 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NILOTINIB71 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]

Package NDCNDC-11Package
24338-154-01243380154014 CARTON in 1 CARTON (24338-154-01) / 2 BLISTER PACK in 1 CARTON (24338-154-02) / 14 TABLET in 1 BLISTER PACK (24338-154-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d288d165-3505-49bb-9b2e-124490d65f49

Use it

Look up 24338-154 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24338-154 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24338-154. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.